Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
04/13/2017 04/18/2017 04/19/2017 04/20/2017 04/21/2017 Date
106.55(c) 104.2(c) 104.5(c) 104.4(c) 105.2(c) Last
1 804 198 2 088 056 1 709 899 1 498 150 2 785 967 Volume
+0.28% -2.21% +0.29% -0.10% +0.77% Change
More quotes
Financials (€)
Sales 2017 49 465 M
EBIT 2017 9 946 M
Net income 2017 5 448 M
Debt 2017 10 494 M
Yield 2017 2,71%
Sales 2018 51 999 M
EBIT 2018 10 156 M
Net income 2018 5 907 M
Debt 2018 9 234 M
Yield 2018 2,92%
P/E ratio 2017 16,52
P/E ratio 2018 15,34
EV / Sales2017 1,97x
EV / Sales2018 1,85x
Capitalization 86 995 M
More Financials
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
04/27Earnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
04/05DJVECTURA : Bayer Launches New Nebuliser in Poland; Triggers Milestone Payment
04/01 NOT INTENDED FOR U.S. AND UK MEDIA - : -- Phase II Copanlisib Data Show Durable ..
03/31 BAYER : Introducing the First Italian Bayer ForwardFarm
03/28DJDuPont, Dow Get EU Approval for Merger -- WSJ
03/27DJEU Clears Dow-DuPont Deal With Conditions -- 2nd Update
03/27DJEU Clears Dow-DuPont Deal With Conditions -- Update
03/22 NOT INTENDED FOR U.S. AND UK MEDIA - : -- Bayer to Showcase Data on Growing Onco..
03/10DJCorrection to PPG Makes $22 Billion Offer for AkzoNobel Story on Thursday
03/10DJAkzo Nobel Shuns $22 Billion Takeover Bid -- WSJ
03/01 Banks, builders boost European shares as Trump-trade back on
More news
Sector news : Pharmaceuticals - NEC
04/22DJNOVARTIS : Tests New Alzheimer's Drug on People Who Don't Have the Disease
04/21DJFDA OKs Samsung Bioepis's biosimilar version of J&J's Remicade
04/21 Teva's new asthma inhaler poses first competition for GSK's Advair
04/19DJSHIRE : Files 8K - Other Events
04/19DJFARON PHARMACEUTICALS OY : Appoints Two Non-Executive Directors
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2016Good timing to anticipate the return of volatility
2016A technical turn-around configuration
More Strategies
Latest Tweets
04/23Chelsea Clinton had a firm response to Vanessa Bayer's awkward Hillary joke: .. 
04/23Chelsea Clinton Defends Potential Woman President After Vanessa Bayer’s Joke .. 
04/23Chelsea Clinton responds to Vanessa Bayer's awkward election joke
13
04/23Chelsea Clinton responded to a Hillary joke by star Vanessa Bayer at Variety..
8
04/23Alexei Bayer: Watch out #Ukraine, this is how Trump is learning from Putin;
2
More tweets
Qtime:206
News from SeekingAlpha
04/21 Keep It 100
04/17 Roche's emicizumab shows treatment benefit in second late-stage hemophilia A ..
04/13 BIOVERATIV : Just Stop The Bleeding
04/11 Double Trouble Sinks Oncomed As Investors Look To Earlier Assets
04/10 OncoMed misses endpoint on clinical trial; Bayer will not license two drugs
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 111 €
Spread / Average Target 5,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG5.32%93 299
JOHNSON & JOHNSON5.69%330 078
ROCHE HOLDING LTD.8.21%217 624
PFIZER INC.3.88%200 330
NOVARTIS AG-1.15%192 857
MERCK & CO., INC.5.13%169 673
More Results